Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives. (2nd September 2019)

• Record Type: Journal Article
• Authors: Rocca, Maria A.; Preziosa, Paolo; Filippi, Massimo
• Is Part Of: Expert review of neurotherapeutics. Volume 19:Number 9(2019)
• Page Start: 835
• Page End: 866
• Publication Date: 2019-09-02
• Subjects: Disease modifying treatments -- magnetic resonance imaging -- multiple sclerosis -- rehabilitation -- treatment monitoring; Neuropharmacology -- Periodicals; 615.7805
• DOI: 10.1080/14737175.2019.1555038
• Languages: English
• ISSNs: 1473-7175

Abstract

ABSTRACT: Introduction : Advances in magnetic resonance imaging (MRI) technology and analyses are improving our understanding of the pathophysiology of multiple sclerosis (MS). Due to their ability to grade the presence of irreversible tissue loss, microstructural tissue abnormalities, metabolic changes and functional plasticity, the application of these techniques is also expanding our knowledge on the efficacy and mechanisms of action of different pharmacological and rehabilitative treatments. Areas covered : This review discusses recent findings derived from the application of advanced MRI techniques to evaluate the structural and functional substrates underlying the effects of pharmacologic and rehabilitative treatments in patients with MS. Current applications as outcome in clinical trials and observational studies, their interpretation and possible pitfalls in their use are discussed. Finally, how these techniques could evolve in the future to improve monitoring of disease progression and treatment response is examined. Expert commentary : The number of treatments currently available for MS is increasing. The application of advanced MRI techniques is providing reliable and specific measures to better understand the targets of different treatments, including neuroprotection, tissue repair, and brain plasticity. This is a fundamental progress to move toward personalized medicine and individual treatment selection.